Registered Phase-1b 12-week study investigating safety, diabetes control, and weight loss KELOWNA, BC – Lexaria Bioscience Corp. (NASDAQ:LEXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is… Read More
Over 100,000 patients in the United States have IPF, with only two approved therapies available that only slow the course of disease progression Top line data expected in the first half of… Read More
TORONTO, ON – In 1980, Terry Fox’s Marathon of Hope united Canadians in a country-wide movement to end cancer. Forty-five years later, Terry Fox Foundation and Terry Fox Research Institute… Read More
KIRKLAND, QC – On World Cancer Day, Merck Canada is launching a new campaign called “Listen Close” to raise awareness for lung cancer and empower Canadians to act for their… Read More
RESEARCH TRIANGLE PARK, NC – IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, was named No. 1 in its category on the 2025… Read More
